ArticleHuman vaccines & immunotherapeutics2022
Near complete response to a pembrolizumab-based therapeutic strategy in an abdominal metastatic head and neck squamous cell carcinoma case.
Taowei Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.